These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 18436116

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
    White HD, Ohman EM, Lincoff AM, Bertrand ME, Colombo A, McLaurin BT, Cox DA, Pocock SJ, Ware JA, Manoukian SV, Lansky AJ, Mehran R, Moses JW, Stone GW.
    J Am Coll Cardiol; 2008 Sep 02; 52(10):807-14. PubMed ID: 18755342
    [Abstract] [Full Text] [Related]

  • 4. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial.
    Stone GW, White HD, Ohman EM, Bertrand ME, Lincoff AM, McLaurin BT, Cox DA, Pocock SJ, Ware JH, Feit F, Colombo A, Manoukian SV, Lansky AJ, Mehran R, Moses JW, Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial investigators.
    Lancet; 2007 Mar 17; 369(9565):907-19. PubMed ID: 17368152
    [Abstract] [Full Text] [Related]

  • 5. Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: an ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) substudy.
    Mehran R, Nikolsky E, Lansky AJ, Kirtane AJ, Kim YH, Feit F, Manoukian S, Moses JW, Ebrahimi R, Ohman EM, White HD, Pocock SJ, Dangas GD, Stone GW.
    JACC Cardiovasc Interv; 2009 Aug 17; 2(8):748-57. PubMed ID: 19695543
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Safety and efficacy of bivalirudin monotherapy in patients with non-ST-segment elevation acute coronary syndromes with positive biomarkers undergoing percutaneous coronary intervention: a report from the Acute Catheterization and Urgent Intervention Triage Strategy trial.
    Huang X, Chen S, Redfors B, Zhang Y, Souza CF, Mehran R, Bansilal S, Kirtane AJ, Brener SJ, Feite F, Dangas GD, Ben-Yehuda O, Stone GW.
    Coron Artery Dis; 2020 Jan 17; 31(1):59-65. PubMed ID: 31809479
    [Abstract] [Full Text] [Related]

  • 8. Impact of gender and antithrombin strategy on early and late clinical outcomes in patients with non-ST-elevation acute coronary syndromes (from the ACUITY trial).
    Lansky AJ, Mehran R, Cristea E, Parise H, Feit F, Ohman EM, White HD, Alexander KP, Bertrand ME, Desmet W, Hamon M, Stone GW.
    Am J Cardiol; 2009 May 01; 103(9):1196-203. PubMed ID: 19406258
    [Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of bivalirudin in high-risk patients admitted through the emergency department.
    Miller CD, Blomkalns AL, Gersh BJ, Pollack CV, Brogan GX, Diercks DB, Peacock WF, Stone GW, Hollander JE, Manoukian SV, Hoekstra JW, ACUITY Investigators.
    Acad Emerg Med; 2009 Aug 01; 16(8):717-25. PubMed ID: 19673711
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial.
    Stone GW, Ware JH, Bertrand ME, Lincoff AM, Moses JW, Ohman EM, White HD, Feit F, Colombo A, McLaurin BT, Cox DA, Manoukian SV, Fahy M, Clayton TC, Mehran R, Pocock SJ, ACUITY Investigators.
    JAMA; 2007 Dec 05; 298(21):2497-506. PubMed ID: 18056903
    [Abstract] [Full Text] [Related]

  • 13. Bivalirudin versus heparin plus a glycoprotein IIb/IIIa inhibitor in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention after clopidogrel pretreatment: pooled analysis from the ACUITY and ISAR-REACT 4 trials.
    Ndrepepa G, Neumann FJ, Deliargyris EN, Mehran R, Mehilli J, Ferenc M, Schulz S, Schömig A, Kastrati A, Stone GW.
    Circ Cardiovasc Interv; 2012 Oct 05; 5(5):705-12. PubMed ID: 23048052
    [Abstract] [Full Text] [Related]

  • 14. Bivalirudin for patients with acute coronary syndromes.
    Stone GW, McLaurin BT, Cox DA, Bertrand ME, Lincoff AM, Moses JW, White HD, Pocock SJ, Ware JH, Feit F, Colombo A, Aylward PE, Cequier AR, Darius H, Desmet W, Ebrahimi R, Hamon M, Rasmussen LH, Rupprecht HJ, Hoekstra J, Mehran R, Ohman EM, ACUITY Investigators.
    N Engl J Med; 2006 Nov 23; 355(21):2203-16. PubMed ID: 17124018
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of bivalirudin in patients with diabetes mellitus undergoing percutaneous coronary intervention in current clinical practice.
    Kim LK, Wong SC, Minutello RM, Bergman G, Feldman DN.
    J Invasive Cardiol; 2010 Mar 23; 22(3):94-100. PubMed ID: 20197573
    [Abstract] [Full Text] [Related]

  • 16. Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
    Lincoff AM, Steinhubl SR, Manoukian SV, Chew D, Pollack CV, Feit F, Ware JH, Bertrand ME, Ohman EM, Desmet W, Cox DA, Mehran R, Stone GW, Acute Catheterization and Urgent Intervention Triage strategY of Trial Investigators.
    JACC Cardiovasc Interv; 2008 Dec 23; 1(6):639-48. PubMed ID: 19463378
    [Abstract] [Full Text] [Related]

  • 17. Advanced age, antithrombotic strategy, and bleeding in non-ST-segment elevation acute coronary syndromes: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
    Lopes RD, Alexander KP, Manoukian SV, Bertrand ME, Feit F, White HD, Pollack CV, Hoekstra J, Gersh BJ, Stone GW, Ohman EM.
    J Am Coll Cardiol; 2009 Mar 24; 53(12):1021-30. PubMed ID: 19298914
    [Abstract] [Full Text] [Related]

  • 18. Bivalirudin during primary PCI in acute myocardial infarction.
    Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Dangas G, Wong SC, Kirtane AJ, Parise H, Mehran R, HORIZONS-AMI Trial Investigators.
    N Engl J Med; 2008 May 22; 358(21):2218-30. PubMed ID: 18499566
    [Abstract] [Full Text] [Related]

  • 19. Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale.
    Stone GW, Bertrand M, Colombo A, Dangas G, Farkouh ME, Feit F, Lansky AJ, Lincoff AM, Mehran R, Moses JW, Ohman M, White HD.
    Am Heart J; 2004 Nov 22; 148(5):764-75. PubMed ID: 15523305
    [Abstract] [Full Text] [Related]

  • 20. Prognostic significance of elevated baseline troponin in patients with acute coronary syndromes and chronic kidney disease treated with different antithrombotic regimens: a substudy from the ACUITY trial.
    Acharji S, Baber U, Mehran R, Fahy M, Kirtane AJ, Lansky AJ, Stone GW.
    Circ Cardiovasc Interv; 2012 Apr 22; 5(2):157-65. PubMed ID: 22354934
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.